Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press activity in Media Coverage, and Taconic's commitment to being Models For Life™.

Taconic Biosciences Adds New Humanized Immune System (HIS) Model to its Portfolio for Immuno-Oncology Research

Taconic Biosciences Adds New Humanized Immune System (HIS) Model to its Portfolio for Immuno-Oncology Research

NEW huNOG-EXL EA MODEL EXTENDS STUDY WINDOWS SIGNIFICANTLY Rensselaer, NY — January 18, 2022 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the huNOG-EXL EA (Early Access) humanized immune system (HIS) mouse. This product expands Taconic's widely used HIS portfolio. huNOG-EXL EA significantly lengthens the study window during which a myeloid-lineage HIS mouse model can be used successfully....  Read More

The Multifaceted Challenge of Modeling Alzheimer's Disease

The Multifaceted Challenge of Modeling Alzheimer's Disease

There are myriad hypotheses on the mechanisms at work in Alzheimer's disease, posing significant challenges for investigators. In this article in Genetic Engineering & Biotechnology News, Taconic Biosciences' Dr. Moriah Jacobson explores the complex mechanisms underlying Alzheimer's disease, the disease-specific mouse models currently available, and how they must evolve to better model sporadic disease, which accounts for about 95 percent of cases. Dr. Jacobson discusses strategies such...  Read More

Taconic Biosciences Announces Academic Grant Program Winners

Taconic Biosciences Announces Academic Grant Program Winners

Winners have been selected for cycle 1 of the Academic Grant Program In May 2021, Taconic Biosciences invited scientists from the nonprofit sector to participate in a new Academic Grant Program. The Program invited applications for projects focusing on key questions related to four model categories: NASH, the NOG Portfolio, humanized immune system (HIS) mice, and inflammatory bowel disease (IBD). Each applicant was tasked with crafting a...  Read More

The American Red Cross Partners with Taconic Biosciences for Blood Drive

The American Red Cross Partners with Taconic Biosciences for Blood Drive

Hundreds of thousands of donors and blood drive hosts like Taconic Biosciences have responded to the call to support this lifesaving mission. As part of our ongoing commitment to community service, Taconic has been partnering with the American Red Cross to host these blood drives and contribute to crucial care for patients for the past few years. In Q4 2020, Taconic earned a Certificate of Outstanding Service...  Read More

Adapting Your Preclinical Animal Model Strategies for a New World

Adapting Your Preclinical Animal Model Strategies for a New World

In the wake of COVID-19, investigators in the commercial and nonprofit sectors are facing heightened pressure to accelerate drug discovery and speed time to market with efficacious therapies, while maintaining high quality and operating within constrained budgets. In an article in International Biopharmaceutical Industry, Dr. Austin Jelcick of Taconic Biosciences reviews the post-COVID trends reshaping the drug discovery landscape, how research organizations are pivoting, and the model...  Read More

Immune Checkpoint Inhibitors: What are the Risks?

Immune Checkpoint Inhibitors: What are the Risks?

Immune checkpoint inhibitors are highly efficacious in some cancer patients, but not others, and they can induce unintended immune activation that results in neurotoxicity or other adverse events. In this Q&A with the editor of Drug Discovery World, Taconic Biosciences' Dr. Courtney Ferrebee discusses the risks and limitations of T-cell based immunotherapies and the importance of considering target activation of a broader range of other immune cell...  Read More

Taconic Biosciences Launches TruIMPORT™ Importation Solution

Taconic Biosciences Launches TruIMPORT™ Importation Solution

Rodent Models Originating in China Can Be Imported Into Virtually Any Academic Vivarium Without Quarantine Rensselaer, NY — May 27, 2021 - Rensselaer, NY, - May 27, 2021 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces a significant enhancement to the Taconic-Cyagen Model Generation Alliance allowing seamless importation of new genetically engineered models originating in China under the TruIMPORT™ umbrella. Researchers...  Read More

Podcast: Models for Long COVID

Podcast: Models for Long COVID

After recovering from COVID-19 infection, many people experience a diverse range of lingering symptoms that have perplexed both physicians and scientists. In a conversation with Dr. Terina Martinez, Nature writer Vivien Marx explores the underpinnings of long COVID and how mouse models, like those offered by Taconic, are evolving to support studies on this puzzling phenomenon: “...we do know from other viruses that viruses can trigger auto-immune...  Read More

Scientists Set Out to Connect the Dots on Long COVID

Scientists Set Out to Connect the Dots on Long COVID

Millions of people who've been infected by COVID-19 battle lingering and often puzzling symptoms, including fatigue, joint pain, respiratory problems, and "brain fog." A recent article in Nature Methods reviews the complexities of long COVID, how researchers are working to identify its causes, and the role that mouse models are playing in this vital investigatory work. The article provides details on several Taconic COVID-19 models available or...  Read More

Meeting the Need for COVID-19 Models

Meeting the Need for COVID-19 Models

The demand for models to support SARS-CoV-2 research has evolved since the onset of the pandemic, continually shifting as investigators learn more about the mechanisms of the virus. A recent article in Lab Animal reviews how model providers like Taconic Biosciences are responding to the urgent, ever-changing need for mouse models uniquely suited to COVID-19 research. Taconic models discussed in the article include hACE2 lines originally developed...  Read More

Close

Welcome! Tell us a little about yourself